Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, New Jersey (Ruiz-White, Wong, and Lonergan).
Dr Ruiz-White is not currently affiliated with Otsuka Pharmaceutical Development & Commercialization, Inc. but was at the time of the writing of the manuscript.
J Clin Psychiatry. 2023 Jun 12;84(4):23ah14887. doi: 10.4088/JCP.23ah14887.
Historically, in the United States, scientific racism has been used to justify differential treatment of Black, Indigenous, People of Color (BIPOC) populations compared with the White population. Discrimination toward BIPOC populations by the medical community has contributed to racial and ethnic disparities in health care that persist to this day. At the 2022 American Society of Clinical Psychopharmacology Annual Meeting, a panel of 5 experts from the areas of academia, advocacy, and clinical research discussed racial and ethnic disparities in mental health care. This Academic Highlights summarizes and expands on that discussion by tracing the history of scientific racism from the colonization of the US to present-day health inequities, illustrating the ongoing problem of low diversity in clinical trials, and outlining solutions through community engagement.
从历史上看,在美国,科学种族主义被用来为对黑人、原住民和有色人种(BIPOC)与白人相比的不同待遇提供正当理由。医学界对 BIPOC 人群的歧视导致了医疗保健方面至今仍存在的种族和族裔差异。在 2022 年美国临床精神药理学学会年会上,一个由来自学术界、宣传和临床研究领域的 5 名专家组成的小组讨论了精神保健方面的种族和族裔差异。本学术要点通过追溯从美国殖民时期到当今健康不平等现象的科学种族主义历史,说明了临床试验中多样性低的持续问题,并通过社区参与勾勒出解决方案,对该讨论进行了总结和扩展。